We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

US Centers for Disease Control and Prevention Installs TAP’s CompacT SelecT To Improve the Quality of Cells for Disease Prevention Programmes


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "US Centers for Disease Control and Prevention Installs TAP’s CompacT SelecT To Improve the Quality of Cells for Disease Prevention Programmes"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 

CDC’s Cell Culture Development Laboratory in Atlanta, Georgia, has recently installed the CompacT SelecT and researchers there are currently validating the system for the culture of MDCK cells that are used for growing influenza viruses. In the future, they plan to validate the system to grow Vero E6 cell lines for use in generating other viruses.

Increased demand for MDCK cell lines during the 2009 H1N1 pandemic prompted CDC to decide to move to an automated system to preserve staff resources and decrease the risk of laboratory contamination.  

Tim Ward, Director of Cell Culture at TAP, said: “We are delighted a major disease prevention centre will be using our system for crucial cell culture programmes. The CDC’s use of CompacT SelecT will enhance productivity and help eliminate contamination risk, which will improve the reliability and consistency of cells. Those receiving cells from the CDC will benefit by having greater confidence that they are using optimum quality cells for applications such as vaccine research and production.”

Advertisement